These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 463884)
41. [Use of prolonged intravenous infusions of cisplatin in patients with malignant neoplasms]. Tiuliadin SA Vopr Onkol; 1983; 29(12):40-4. PubMed ID: 6582683 [TBL] [Abstract][Full Text] [Related]
42. A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal. Alam K; Mishra P; Prabhu M; Shankar PR; Palaian S; Bhandari RB; Bista D Kathmandu Univ Med J (KUMJ); 2006; 4(4):436-43. PubMed ID: 18603950 [TBL] [Abstract][Full Text] [Related]
44. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate. Canal P; de Forni M; Chatelut E; Chevreau C; Johnson NP; Houin G; Bugat R Acta Med Austriaca; 1989; 16(3-4):84-6. PubMed ID: 2609919 [TBL] [Abstract][Full Text] [Related]
45. Treatment of ovarian cancer with intraperitoneal cisplatin. Espinosa E; Zamora P N Engl J Med; 1997 Jun; 336(23):1674; author reply 1675. PubMed ID: 9173272 [No Abstract] [Full Text] [Related]
46. Trends in intravenous additive programs; the report of a research study. Moravec DF Hosp Manage; 1970 Mar; 109(3):58-62. PubMed ID: 5414987 [No Abstract] [Full Text] [Related]
47. Premixed intravenous admixtures: a positive development for hospital pharmacy. Lee HE Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393 [TBL] [Abstract][Full Text] [Related]
49. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group. Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123 [TBL] [Abstract][Full Text] [Related]
50. Computerizing cuts prescribing of psychotropics. Med World News; 1978 Sep; 19(18):11-2. PubMed ID: 10316683 [No Abstract] [Full Text] [Related]
51. Intravenous admixture training program for pharmacy personnel. Hunt ML Am J Hosp Pharm; 1974 May; 31(5):467-71. PubMed ID: 4829388 [No Abstract] [Full Text] [Related]
53. Data processing system supplies intravenous additive information. Hodges TH; Allen SI Hospitals; 1968 Nov; 42(22):103-5. PubMed ID: 5688330 [No Abstract] [Full Text] [Related]
54. Premixed intravenous admixtures: a critical challenge for hospital pharmacy. Loeb AJ; Fishman DA; Kochis TR Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392 [TBL] [Abstract][Full Text] [Related]
55. Effect of a cancer chemotherapy prescription form on prescription completeness. Thorn DB; Sexton MG; Lemay AP; Sarigianis JS; Melita DD; Gustafson NJ Am J Hosp Pharm; 1989 Sep; 46(9):1802-6. PubMed ID: 2801713 [TBL] [Abstract][Full Text] [Related]
56. Effect of implementing a cancer chemotherapy order form on prescribing habits for parenteral antineoplastics. Pastel DA; Fay P; Lee D Hosp Pharm; 1993 Dec; 28(12):1192-5. PubMed ID: 10130616 [TBL] [Abstract][Full Text] [Related]
57. Computerized order entry: hospital versus pharmacy-based systems. Poikonen J Am J Hosp Pharm; 1990 Nov; 47(11):2461-2. PubMed ID: 2278252 [No Abstract] [Full Text] [Related]
58. The current status of parenteral hyperalimentation. Flack HL; Gans JA; Serlick SE; Dudrick SJ Am J Hosp Pharm; 1971 May; 28(5):326-35. PubMed ID: 4999686 [No Abstract] [Full Text] [Related]
59. [On the work of the committees for scientific prescriptions]. Michael R Pharm Prax; 1966; 2():35-40. PubMed ID: 5914263 [No Abstract] [Full Text] [Related]
60. Beneficial effect of a pharmacist refill evaluation clinic. Jones RJ; Goldman MP; Rockwood RP; Imhoff TE Hosp Pharm; 1987 Feb; 22(2):166-8. PubMed ID: 10280300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]